Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology

Overview of attention for article published in Frontiers in oncology, February 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 18 X posts from 16 X users, with an upper bound of 117,044 followers.

RT @metabostemness: #Metformin: Targeting the Metabolo-Epigenetic Link in #Cancer Biology is now out in @FrontOncology https://t.co/hDkZs…

RT @Brunorm84: Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology @FrontOncology https://t.co/25bf6zaAcD

RT @Brunorm84: Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology @FrontOncology https://t.co/25bf6zaAcD

RT @Brunorm84: Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology @FrontOncology https://t.co/25bf6zaAcD

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.